These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 28373257)

  • 1. Prevalence and influencing factors of hepatitis B among a rural residential population in Zhejiang Province, China: a cross-sectional study.
    Yang S; Ding C; Cui Y; Wu J; Yu C; Chen P; Xu K; Deng M; Li Y; Liu J; Yin P; Ren W; Qiu Y; Cao Q; Zhou Y; Yao J; Ruan B; Ren J; Li L
    BMJ Open; 2017 Apr; 7(4):e014947. PubMed ID: 28373257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey.
    Olayinka AT; Oyemakinde A; Balogun MS; Ajudua A; Nguku P; Aderinola M; Egwuenu-Oladejo A; Ajisegiri SW; Sha'aibu S; Musa BO; Gidado S; Nasidi A
    Am J Trop Med Hyg; 2016 Oct; 95(4):902-907. PubMed ID: 27527630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis B prevalence among women in child-bearing age in Shandong Province, China, 2014].
    Zhang L; Liu JY; Lyu JJ; Yan BY; Feng Y; Wu WL; Song LZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):475-479. PubMed ID: 28592088
    [No Abstract]   [Full Text] [Related]  

  • 4. A population-based study examining hepatitis B virus infection and immunization rates in Northwest China.
    Ji Z; Wang T; Shao Z; Huang D; Wang A; Guo Z; Long Y; Zhang L; Su H; Zhang Q; Yan Y; Fan D
    PLoS One; 2014; 9(5):e97474. PubMed ID: 24832483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania: a nationwide survey.
    Gheorghe L; Csiki IE; Iacob S; Gheorghe C
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):56-64. PubMed ID: 22968488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in central China.
    Yonghao G; Jin X; Jun L; Pumei D; Ying Y; Xiuhong F; Yanyang Z; Wanshen G
    Int J Infect Dis; 2015 Nov; 40():75-80. PubMed ID: 26456567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of HBV vaccination in infants and prediction of HBV prevalence trend under new vaccination plan: findings of a large-scale investigation.
    Yang SG; Wang B; Chen P; Yu CB; Deng M; Yao J; Zhu CX; Ren JJ; Wu W; Ju B; Shen JF; Chen Y; Li MD; Ruan B; Li L
    PLoS One; 2012; 7(10):e47808. PubMed ID: 23094094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seroepidemiological analysis of hepatitis B among children aged 1-14 in 3 counties of Guangdong province in 2013].
    Shao X; Wu C; Wang F; Liang J; Xie X; Zhu Q; Liu J; Hu P; Qiu Q; Liang X; Zheng H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):777-81. PubMed ID: 26733134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China.
    Yang S; Yu C; Chen P; Deng M; Cao Q; Li Y; Ren J; Xu K; Yao J; Xie T; Wang C; Cui Y; Ding C; Tian G; Wang B; Zhang X; Ruan B; Li L
    Sci Rep; 2015 Dec; 5():18334. PubMed ID: 26655735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiology of hepatitis B virus infection among children in Mongolia: results of a nationwide survey.
    Davaalkham D; Ojima T; Nymadawa P; Tsend N; Lkhagvasuren T; Wiersma S; Uehara R; Watanabe M; Oki I; Nakamura Y
    Pediatr Int; 2007 Jun; 49(3):368-74. PubMed ID: 17532838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
    Zhao S; Xu Z; Lu Y
    Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary prevention by hepatitis B vaccine on liver cancer in high incidence area of China].
    Wang YT; Chen TY; Zhu J; Jiao YC; Qu CF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Apr; 52(4):402-408. PubMed ID: 29614608
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of hepatitis B vaccination among children in Guangdong Province, China.
    Xiao J; Zhang J; Wu C; Shao X; Peng G; Peng Z; Ma W; Zhang Y; Zheng H
    Int J Infect Dis; 2012 Sep; 16(9):e692-6. PubMed ID: 22795176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the duplicate notifiable reporting of hepatitis B infection in Zhejiang province, China, 2005-2015.
    He H; Zhou Y; Xie S
    Vaccine; 2017 Aug; 35(36):4702-4706. PubMed ID: 28750855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China].
    Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological serosurvey of hepatitis B virus among children aged 1-14 years in Guangdong Province, China.
    Zhu Q; Shao X; Chen S; Li D; Chen X; Liu W; Wu X; Jian Z; Rutherford S; Zheng H
    Int J Infect Dis; 2018 Jun; 71():25-29. PubMed ID: 29408358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
    Zhou Y; He H; Deng X; Yan R; Tang X; Xie S; Yao J
    Vaccine; 2017 Aug; 35(34):4355-4361. PubMed ID: 28687404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiological characteristics of children aged 1-4 years without timely birth dose of hepatitis B vaccine vaccination in China, 2014].
    Wang FZ; Zhang GM; Shen LP; Liu JH; Zheng H; Wang F; Miao N; Sun XJ; Liang XF; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):32-36. PubMed ID: 28100373
    [No Abstract]   [Full Text] [Related]  

  • 20. [The epidemiological characteristics of HBV susceptibility in 1-29 years old young people in China in 2006 and 2014: based on the national sero-survey data analysis].
    Zheng H; Wang FZ; Zhang GM; Miao N; Sun XJ; Cui FQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):581-586. PubMed ID: 28693080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.